No Data
Sino-agri leading biosciences (603970.SH): Some products such as avermectin, methyldifluoroacetate, florfenicol and other varieties have experienced a temporary price increase.
Gelonghui November 4th | Sino-Agri Leading Biosciences (603970.SH) stated at an investor relations event that the industry competition is fierce, upstream manufacturers are generally under pressure. Various factors such as rising raw material prices, bearish sentiment on the demand side, manufacturers actively reducing production or implementing production limits, and market inventory situations are impacting product prices. Currently, downstream enterprises are generally adopting a just-in-time purchasing strategy, and some products may experience short-term fluctuations, resulting in continuous intensification of the supply-demand game. The sustainability of product price increases will require actual orders to support. Based on the trend shown by the Sino-Agri Leading Biosciences' raw material price index, most products are expected to continue to maintain bottom-line consolidation. Some products such as avilamycin,
Zhongnong Lihua: Sino-Agri Lihua Report for the Third Quarter of 2024
Zhongnong Lihua Report for the Third Quarter of 2024
Sino-agri leading biosciences (603970): The non-GAAP net income in Q2 24 is 0.099 billion yuan, a year-on-year increase of 11.18%, accelerating the expansion of the domestic field market.
In the first half of 2024, the non-deductible net income was ¥0.153 billion, a year-on-year increase of 9.85%. In the first half of 2024, the company achieved revenue of ¥6.532 billion, a year-on-year increase of 3.92%, mainly due to the increase in pesticide exports. Non-deductible net profit.
Zhongnong Lihua 2024 Semi-Annual Report
Summary of the 2024 Semi-Annual Report of Zhongnong Lihua
No Data
No Data